Skip to main content

Fox Chase Cancer Center in building dispute

A leading cancer center in Philadelphia appears to be winning a battle with city residents to expand its clinical and research facilities. Fox Chase Cancer Center received the green light from a City Council committee Monday night to go ahead with an $800 million expansion. The Ok has been three years in the making because of objections from people who live in the area. The expansion will take up 19 acres of a park in the city, and residents don't want to see the expansion linkurl:"rip the guts

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
A leading cancer center in Philadelphia appears to be winning a battle with city residents to expand its clinical and research facilities. Fox Chase Cancer Center received the green light from a City Council committee Monday night to go ahead with an $800 million expansion. The Ok has been three years in the making because of objections from people who live in the area. The expansion will take up 19 acres of a park in the city, and residents don't want to see the expansion linkurl:"rip the guts out of the park.";https://www.philly.com/philly/news/local/11849442.html Fox Chase Cancer Center linkurl:ranked 9;https://www.the-scientist.com/article/display/24823/ in __The Scientist's__ Best Places to Work in Academia survey in 2006, and linkurl:ranked 35;https://www.the-scientist.com/2007/11/1/63/1 in 2007. It also linkurl:ranked 6;https://www.the-scientist.com/2006/3/1/54/1/ in 2006 among the best places in North America to do a postdoc. In 2004, scientists at Fox Chase received $57 million in grant dollars from the NIH. According to a press release from the Center last year, the intended expansion "is necessary to accommodate new cancer research and the growing number of cancer patients requiring care each year." The Center estimated its patient load will double by 2015. Construction won't begin just yet. Fox Chase still has to get approval from the full City Council, which is expected to meet December 6. Correction (posted November 27. 2007): When originally posted, this article stated that the intended expansion included the Center for Women's Cancers, which is part of an already-approved expansion at Fox Chase. The article also incorrectly stated the expansion is a 125,000 square foot facility, when it is actually several buildings. __The Scientist__ regrets the errors.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo